Look Who's Talking… About Liquid Biopsy TechnologyBy William Patalon III, Executive Editor, Money Morning • June 23, 2016Start the conversationLeave a Reply Click here to cancel reply.Your email address will not be published. Required fields are marked *Name * Email * Website nine − 3 = Comment Some HTML is OK Sign me up for the Money Morning newsletter William Patalon IIII've told this story before, but it bears repeating here...Back in April 2015, about a month after I originally recommended "Liquid Biopsy" stock TrovaGene Inc. (Nasdaq: TROV), biotech-sector executive Tina Nova wrote in a Wired magazine essay that the still-in-development cancer-screening technology is "the most exciting thing I've seen since I started my career."This is premium content for Private Briefing subscribers only. As the executive editor of Money Morning, Bill Patalon has perfected a secret investment strategy that could help you put an extra $125K into your portfolio - this year. To date, Bill has used this strategy to pick 257 winning investments, including 192 double- and triple-digit peak gains. Once you see the secret, you'll immediately understand why it works so well.